Seeking Alpha

xzorro123 » Comments » BMY

  • Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO [View article]
    It is a pity that not also is commented on the 3 encouraging clinical trials of Genvec for :
    1. pancreatic tumor- Phase 3
    2. esophageal tumor- Phase 2
    3. Head and neck tumor: Phase 1

    Genentech is a MegaCap company and GNVC is a SmallCap company. Hence, the effect on GNVC s.p. is most likely more significant.

    DYODD
    Jun 04 11:02 am |Rating: 0 0 |Link to Comment
More on BMY by xzorro123
Comments by Ticker
xzorro123's
Comments Stats
2 comments
Rating: 0 (0 - 0 )